Information  X 
Enter a valid email address

Assura plc (AGR)


Tuesday 01 February, 2022

Assura plc

Total Voting Rights

RNS Number : 2998A
Assura PLC
01 February 2022

1 February 2022

Assura plc

Total Voting Rights

In conformity with the FCA's Disclosure Guidance and Transparency Rules DTR 5.6.1 we hereby notify that the company's issued share capital consists of:

Issued shares and voting rights
2,948,359,637 ordinary shares of 10 pence each ("Shares")

The above figure of 2,948,359,637 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, shares of Assura plc under the FCA's Disclosure and Transparency Rules. No shares are held in treasury.

- Ends -


For more information, please contact:

Assura plc
David Purcell, Head of Investor Relations

Tel: 01925 420680
E mail: [email protected]


Gordon Simpson
James Thompson

Tel: 0207 251 3801
Email: [email protected]


Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at £2,595 million.


Further information is available at


*EPRA is a registered trademark of the European Public Real Estate Association.


Assura plc LEI code: 21380026T19N2Y52XF72



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t